Humana Inc. $HUM Shares Sold by UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC

UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC cut its holdings in Humana Inc. (NYSE:HUM) by 2.0% during the second quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 1,072,296 shares of the insurance provider’s stock after selling 21,480 shares during the quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC’s holdings in Humana were worth $425,937,000 as of its most recent SEC filing.

Other institutional investors and hedge funds have also recently bought and sold shares of the company. Revolve Wealth Partners LLC purchased a new stake in shares of Humana during the 4th quarter worth $202,000. Woodline Partners LP increased its holdings in shares of Humana by 460.0% in the 1st quarter. Woodline Partners LP now owns 10,192 shares of the insurance provider’s stock valued at $2,697,000 after purchasing an additional 8,372 shares in the last quarter. Sivia Capital Partners LLC lifted its stake in shares of Humana by 53.7% in the second quarter. Sivia Capital Partners LLC now owns 1,293 shares of the insurance provider’s stock valued at $316,000 after purchasing an additional 452 shares during the period. Cresset Asset Management LLC lifted its stake in shares of Humana by 10.3% in the second quarter. Cresset Asset Management LLC now owns 2,369 shares of the insurance provider’s stock valued at $581,000 after purchasing an additional 222 shares during the period. Finally, WINTON GROUP Ltd boosted its holdings in Humana by 58.5% during the second quarter. WINTON GROUP Ltd now owns 2,381 shares of the insurance provider’s stock worth $582,000 after buying an additional 879 shares in the last quarter. Institutional investors and hedge funds own 92.38% of the company’s stock.

Analyst Ratings Changes

HUM has been the topic of several recent analyst reports. Evercore upgraded shares of Humana from an “in-line” rating to an “outperform” rating and set a $480.00 target price on the stock in a research report on Wednesday, July 29th. Zacks Research downgraded shares of Humana from a “strong-buy” rating to a “hold” rating in a research report on Tuesday, August 11th. Raymond James Financial lowered Humana from an “outperform” rating to a “market perform” rating in a research note on Thursday, July 30th. Jefferies Financial Group upgraded Humana from a “buy” rating to a “buy” rating in a report on Wednesday, May 20th. Finally, UBS Group assumed coverage on Humana in a research note on Thursday, July 30th. They issued a “buy” rating for the company. Fourteen analysts have rated the stock with a Buy rating, fifteen have issued a Hold rating and one has issued a Sell rating to the company. According to MarketBeat, the stock has an average rating of “Hold” and an average price target of $403.91.

Humana Stock Performance

Shares of HUM opened at $386.92 on Monday. The company has a current ratio of 1.74, a quick ratio of 1.74 and a debt-to-equity ratio of 0.62. The stock has a market cap of $46.46 billion, a P/E ratio of 36.61, a PEG ratio of 2.20 and a beta of 0.72. The company has a 50-day moving average of $385.60 and a two-hundred day moving average of $289.17. Humana Inc. has a 12-month low of $163.11 and a 12-month high of $428.88.

Humana (NYSE:HUM) last announced its quarterly earnings results on Wednesday, July 29th. The insurance provider reported $7.61 earnings per share (EPS) for the quarter, beating the consensus estimate of $7.27 by $0.34. The company had revenue of $40.89 billion for the quarter, compared to the consensus estimate of $40.58 billion. Humana had a net margin of 0.88% and a return on equity of 11.20%. The company’s revenue for the quarter was up 26.2% compared to the same quarter last year. During the same quarter in the prior year, the firm earned $6.27 earnings per share. As a group, research analysts predict that Humana Inc. will post 9.12 EPS for the current fiscal year.

Humana Company Profile

Humana Inc (NYSE: HUM) is a health insurance company headquartered in Louisville, Kentucky, that primarily serves individuals and groups across the United States. The company is best known for its Medicare business, offering Medicare Advantage plans and prescription drug (Part D) coverage, alongside a range of commercial and employer-sponsored group health plans. Humana’s products are designed to cover medical, behavioral health and pharmacy needs for members, with particular emphasis on seniors and Medicare-eligible populations.

In addition to traditional insurance products, Humana provides care-management and wellness services intended to support chronic-condition management, preventive care and care coordination.